SCHEMBL28096943

SCHEMBL28096943

CC(=O)OC(C)c1cccc(OCC(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.46
CYP17A1 P05093 1/20 0.46
CYP2C19 P33261 1/20 0.46
CTSA P10619 1/20 0.43
LMNA P02545 3/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
DUT P33316 1/20 0.40
MAOB P27338 2/20 0.40
CYP1A2 P05177 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PAX8 Q06710 2/20 0.39
S1PR2 O95136 1/20 0.39
S1PR4 O95977 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
XBP1 P17861 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27643007 0.82 GPR139 (0.46) ACHE
SCHEMBL30806732 0.80 CYP2C9 (0.56) CYP2C9CYP17A1CYP2C19CTSAALDH1A1
SCHEMBL28675009 0.80 CACNA1B (0.53) LMNAALDH1A1KDM4ESMN1; SMN2FAAH
SCHEMBL12869064 0.79 KDM4E (0.53) CYP2C9CYP17A1CYP2C19CTSALMNA
SCHEMBL3077103 0.79 CES2 (0.50) LMNASMN1; SMN2MEN1KMT2AHTT
Trifluoroacetic Acid SCHEMBL30117104 0.77 CTSA (0.45) CYP2C9CYP17A1CYP2C19CTSALMNA
SCHEMBL4550352 0.77 CYP2C9 (0.49) CYP2C9CYP17A1CYP2C19CTSAALDH1A1
SCHEMBL21288053 0.77 CYP2C9 (0.49) CYP2C9CYP17A1CYP2C19CTSAALDH1A1
SCHEMBL28822313 0.77 CYP2C9 (0.49) CYP2C9CYP17A1CYP2C19CTSAALDH1A1
SCHEMBL16957784 0.77 CYP2C9 (0.49) CYP2C9CYP17A1CYP2C19CTSAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104011021-B heterocyclic derivatives and their use as prostaglandin D2 receptor modulators 埃科特莱茵药品有限公司 2016-08-24 CN disclosed